Glenmark Pharmaceuticals Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
52523.21 Cr.
|
P/BV
|
6.22
|
Book Value (Rs.)
|
299.28
|
52 Week High/Low (Rs.)
|
1843/1272
|
FV/ML
|
1/1
|
P/E(X)
|
50.16
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
37.10
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
No. of Equity Shares (in Lacs) | 2821.90 | 2821.88 | 2821.68 | 2821.68 | 2821.68 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
Total Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| | | | | |
Reserves and Surplus | 8821.22 | 7801.48 | 9445.71 | 9058.43 | 7036.41 |
Total Reserves and Surplus | 8821.22 | 7801.48 | 9445.71 | 9058.43 | 7036.41 |
Employees Stock Options | 0.00 | 18.23 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 8849.44 | 7847.93 | 9473.92 | 9086.65 | 7064.63 |
Minority Interest | -0.37 | -0.38 | 365.34 | 351.47 | -0.35 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 512.70 | 0.00 | 3852.14 | 2571.74 | 3888.82 |
Deferred Tax Liabilities [Net] | 58.59 | 0.28 | 42.95 | 31.50 | 28.75 |
Other Long Term Liabilities | 662.17 | 692.21 | 591.80 | 352.50 | 420.72 |
Total Non-Current Liabilities | 1233.46 | 692.49 | 4486.89 | 2955.74 | 4338.28 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 1681.50 | 990.60 | 495.58 | 1098.61 | 798.61 |
Trade Payables | 2579.53 | 2535.93 | 2391.86 | 2288.66 | 2237.77 |
Other Current Liabilities | 1109.92 | 1650.94 | 1650.54 | 810.78 | 650.31 |
Short Term Provisions | 596.08 | 641.12 | 507.55 | 491.38 | 514.33 |
Total Current Liabilities | 5967.02 | 5818.59 | 5045.53 | 4689.43 | 4201.02 |
| | | | | |
Total Capital And Liabilities | 16049.55 | 14358.62 | 19371.68 | 17083.29 | 15603.58 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 3612.21 | 3118.15 | 3904.16 | 3690.63 | 2957.78 |
Intangible Assets | 1097.19 | 1024.65 | 2224.61 | 2136.60 | 2113.06 |
Capital Work-In-Progress | 541.99 | 419.32 | 1115.18 | 921.09 | 1217.79 |
Intangible Assets Under Development | 0.00 | 242.56 | 136.08 | 88.78 | 163.88 |
Fixed Assets | 5251.39 | 4804.68 | 7380.02 | 6837.10 | 6452.51 |
Goodwill On Consolidation | 70.27 | 67.36 | 73.62 | 60.02 | 58.01 |
Non-Current Investments | 56.36 | 789.66 | 44.65 | 49.62 | 24.63 |
Deferred Tax Assets [Net] | 1124.11 | 1049.72 | 1805.91 | 1686.12 | 1534.67 |
Other Non-Current Assets | 251.97 | 219.11 | 193.75 | 168.08 | 174.18 |
Total Non-Current Assets | 6754.09 | 6930.54 | 9497.96 | 8800.94 | 8244.00 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Inventories | 3028.53 | 2513.05 | 2977.79 | 2499.83 | 2276.83 |
Trade Receivables | 3341.95 | 1858.41 | 4098.61 | 3101.14 | 2572.06 |
Cash And Cash Equivalents | 1705.23 | 1659.46 | 1469.70 | 1411.52 | 1139.16 |
OtherCurrentAssets | 1219.76 | 1397.16 | 1327.63 | 1269.87 | 1371.53 |
Total Current Assets | 9295.47 | 7428.08 | 9873.72 | 8282.35 | 7359.58 |
| | | | | |
Total Assets | 16049.55 | 14358.62 | 19371.68 | 17083.29 | 15603.58 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 0.00 | 1193.96 | 477.58 | 559.75 | 544.81 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 0.00 | 15.84 | 15.84 | 15.84 | 15.84 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.07 | 0.05 | 0.07 |
Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 44.58 | 49.58 | 24.56 |